Concord Drugs Ltd Closes Trading Window for Audited Results Announcement

Concord Drugs Ltd has announced the closure of its trading window for the purpose of considering audited (standalone and consolidated) results for the quarter and financial year ending 31st March, 2026. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading. The trading window will remain closed from Wednesday, 0lst April 2026 till 48 hours after the announcement/declaration of the audited financial results. Directors, Designated Employees, Insiders, and their immediate relatives are barred from transacting securities of the company during this period. The trading window will open 48 hours after the announcement/declaration of the audited financial results for the quarter and year ending 31st March 2026.